About Acorda Therapeutics

Andrew R. Blight

Everything we do is aimed at improving lives

Millions of people with nervous system disorders are in need of new therapeutic options. We never forget that these people may include our own family members or friends, and that these are not just diseases to be treated, but people who need help to make their lives, and those of their loved ones, better.

In this section, you’ll meet some of the people at Acorda are taking new approaches to developing medications that provide hope for people with nervous system disorders – and go beyond the walls of the company to improve lives. You’ll also find out how our partnerships and grant program are advancing research and education, and the process for submitting grant requests.

Mission Statement

Acorda’s mission is to develop therapies that restore function and improve the lives of people with neurological disorders.

If you’ve been impacted by Hurricane Harvey, Irma, or Maria, and have concerns about your Ampyra (dalfampridine) prescription, please contact your Specialty Pharmacy or Ampyra Patient Support Services at (888) 881-1918

Acorda has acquired Biotie Therapies. We invite you to explore www.acorda.com to learn more about our company, including our continued development of BIotie clinical programs for tozadenant, SYN120 and BTT1023. Information regarding transfers of value made to healthcare professionals and healthcare organizations in connection with Biotie’s clinical development programs is also available.

The website uses cookies, which are text files placed on your computer. Some of these are essential to the site’s operation while others analyse how visitors use the site. These cookies are set by default but you can disable them or view more information about how they are used here. By clicking on continue you consent to our use of cookies.